相关实验视频

Updated: May 10, 2025

Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale

Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale

Published on: May 28, 2021

慢性自发性疹严重程度与TNF-α血清度相关

Thai Van Thanh Le¹, Khanh Huy Mach¹, The Bich Thanh Vuong²

¹Department of Dermatology and Skin Aesthetics, University Medical Center HCMC, Ho Chi Minh City 749000, Vietnam.

Dermatology research and practice

|April 28, 2025

概括

在慢性自发性疹病 (CSU) 患者中,瘤缩因子-α (TNF-alpha) 的血清水平显著升高. 较高的TNF-α与增加的疾病严重性和相关,表明其在CSU病原发生中的作用.

科学领域:

免疫学免疫学免疫学
皮肤病学皮肤病学
细胞因子研究细胞因子研究

背景情况:

慢性自发性疹 (CSU) 是一种常见的皮肤疾病.
虽然组胺是关键的,但细胞因子,如瘤亡因子-α (TNF-α) 也可能参与CSU.
了解TNF-alpha的作用可能会揭示新的治疗点.

研究的目的:

在CSU患者中测量血清TNF-α水平.
调查TNF-alpha和CSU症状严重程度之间的关系.
将CSU患者的TNF-α水平与健康对照进行比较.

主要方法:

招募了60名成年CSU患者和30名健康成年人.
临床严重程度使用疹活动评分7 (UAS7) 进行评估.
使用Avi Bion人类TNF-alpha套件量化血清TNF-alpha水平.

主要成果:

骨髓炎患者的血清TNF-α度明显高于对照组 (p < 0.001).
在血清TNF-α和UAS7得分之间观察到适度的正相关性 (r=0.57,p < 0.001).
血清TNF-alpha也与的得分有中度的正相关性 (r=0.45,p < 0.001).

结论:

在CSU患者中,血清TNF-α显著升高.
提升的TNF-α与增加的CSU活动和相关.
TNF-α可能在CSU病原体中发挥重要作用,这需要进一步调查.

更多相关视频

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody mAb by Neutralizing TNF Using an In Vitro Bioanalytical Method

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody mAb by Neutralizing TNF Using an In Vitro Bioanalytical Method

Published on: September 16, 2017

相关概念视频

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...